The goals of a Phase 2 clinical trial are to determine if the treatment is effective and to gather more safety data. Researchers use the data from Phase 2 trials to refine their research questions ...

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.

IO Biotech plans to meet with the FDA this fall to discuss the data from the phase 3 trial of Cylembio and determine next ...

Athira Pharma (ATHA) presented results from its Phase 1 clinical trial of ATH-1105 in healthy volunteers at the ALS Nexus 2025 conference in ...

H-D Feminine Health, announces it has initiated the first randomized, placebo-controlled, double-blinded Phase 3 clinical trial cleared to proceed by the U.S. Food and Drug Administration (FDA) to ...

Phase 1 Trials There is little ethical discourse and few publications of phase 1 trials involving healthy volunteers. [17, 18] Phase 1 clinical trials are the gatekeepers for all clinical research.

LOS ANGELES-- (BUSINESS WIRE)-- Pelage Pharmaceuticals, a clinical-stage regenerative medicine company, today announced positive results from its Phase 2a clinical trial of PP405 — a topical ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...

Espoo, Finland, 14 August 2025: Herantis Pharma Plc ("Herantis"), a clinical-stage company developing disease-modifying therapies to stop Parkinson’s disease, announces that the last patient visit has ...

Phase 1 study results published in Nature Medicine looks at a vaccine for patients with pancreatic and colorectal cancer. Dr Magnus Dillon, Clinician Scientist at The Institute of Cancer Research, ...

Cameroon court rejects opposition leader's candidacy for October presidential vote: lawyer Nucleus Network, a global leader in early phase clinical research, today announced the acquisition of ...

Dr. Shamoo's critique reveals the essential hypocrisy of the biomedical research enterprise in plying largely poor healthy individuals with money to participate in risky phase 1 clinical trials ...